Home
>
US Stocks
>
Redhill Biopharma - ADR
Redhill Biopharma - ADR
RDHL

Redhill Biopharma - ADR

$4.881.24%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
4.91
Today Low/High
4.84 / 4.96
52 Week Low/High
$4.14 / $11.52
Market Cap
$224.94M

Company Details

RedHill Biopharma Ltd. is a specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs, Movantik® for opioid-induced constipation in adults, Talicia® for the treatment of Helicobacter pylori (H. pylori) infection in adults, and Aemcolo® for the treatment of travelers' diarrhea in adults. RedHill's key clinical late-stage development programs include: (i) RHB-204, with an ongoing Phase 3 study for pulmonary nontuberculous mycobacteria (NTM) disease; (ii) opaganib (Yeliva®, ABC294640), a first-in-class SK2 selective inhibitor targeting multiple indications with a Phase 2/3 program for COVID-19 and Phase 2 studies for prostate cancer and cholangiocarcinoma ongoing; (iii) RHB-107 (upamostat), a serine protease inhibitor in a U.S. Phase 2/3 study as treatment for symptomatic COVID-19, and targeting multiple other cancer and inflammatory gastrointestinal diseases; (iv) RHB-104, with positive results from a first Phase 3 study for Crohn's disease; (v) RHB-102 (Bekinda®), with positive results from a Phase 3 study for acute gastroenteritis and gastritis and positive results from a Phase 2 study for IBS-D; and (vi) RHB-106, an encapsulated bowel preparation.
Organisation
Redhill Biopharma - ADR
Headquaters
21 Haarbaa St, Tel Aviv Yafo, Israel
Employees
182
Industry
Health Technology
CEO
Dror Ben-Asher

Discover more

Frequently Asked Questions

What is Redhill Biopharma - ADR share price today

Can Indians buy Redhill Biopharma - ADR shares?

How can I buy Redhill Biopharma - ADR shares from India?

Can Fractional shares of Redhill Biopharma - ADR be purchased?

What are the documents required to start investing in Redhill Biopharma - ADR stocks?

We are a SEBI registered investement advisor